Posted on 08/12/20
| News Source: MATZAV
The United States has entered an agreement with drugmaker Moderna Inc. to acquire 100 million doses of its potential COVID-19 vaccine for around $1.5 billion, the company and White House said Tuesday.
The United States in recent weeks has made deals to acquire hundreds of millions of doses of potential COVID-19 vaccines from several companies as part of its Operation Warp Speed program, which aims to deliver a vaccine in the country by the end of the year.
Moderna’s price per dose comes to around $30.50 per person for a two dose regimen.
With the exception of its deal with AstraZeneca, which offered a lower price per drug in exchange for upfront research and development costs, all the deals price COVID-19 vaccines between $20 to $42 for a two dose course of treatment.
Read more at NEWSMAX.